From Wikipedia, the free encyclopediaJump to navigation Jump to search
|Source||Humanized (from mouse)|
|Chemical and physical data|
|Molar mass||146.4 kg/mol g·mol−1|
|NY (what is this?)|
Dalotuzumab is a humanized monoclonal antibody designed for the treatment of cancers.
Dalotuzumab was developed by Merck & Co., Inc.
|This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.|
|This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.|